Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone - PubMed (original) (raw)
Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone
N L Davis et al. Virology. 1991 Jul.
Abstract
Attenuated mutants of Venezuelan equine encephalitis virus (VEE) were isolated by selection for rapid penetration of cultured cells (R. E. Johnston and J. F. Smith, 1988, Virology 162, 437-443). Sequence analysis of these mutants identified candidate attenuating mutations at four loci in the VEE E2 glycoprotein gene: a double mutation at E2 codons 3 and 4, and single substitutions at E2 76, 120, and 209. Each candidate mutation was reproduced in an isogenic recombinant VEE strain using site-directed mutagenesis of a full-length cDNA clone of VEE. Characterization of these molecularly cloned mutant viruses showed that mutation at each of the four loci in the E2 gene was sufficient to confer both the accelerated penetration and attenuation phenotypes. Inoculation of the molecularly cloned viruses into rodent models that differ in their response to VEE suggested that individual mutations affected different aspects of VEE pathogenesis. Full-length clones containing multiple mutations were produced by combining independently attenuating mutations. Molecularly cloned viruses carrying two or three mutations were more attenuated in sensitive animal models than viruses which contained any single mutation alone. However, these highly attenuated strains still retained the ability to induce an immune response sufficient to protect against a high dose challenge with virulent VEE. These results indicate that production of a molecularly cloned live virus vaccine for VEE is feasible.
Similar articles
- A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis.
Davis NL, Grieder FB, Smith JF, Greenwald GF, Valenski ML, Sellon DC, Charles PC, Johnston RE. Davis NL, et al. Arch Virol Suppl. 1994;9:99-109. doi: 10.1007/978-3-7091-9326-6_11. Arch Virol Suppl. 1994. PMID: 8032286 - A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.
Aronson JF, Grieder FB, Davis NL, Charles PC, Knott T, Brown K, Johnston RE. Aronson JF, et al. Virology. 2000 Apr 25;270(1):111-23. doi: 10.1006/viro.2000.0241. Virology. 2000. PMID: 10772984 - Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.
Davis NL, Brown KW, Greenwald GF, Zajac AJ, Zacny VL, Smith JF, Johnston RE. Davis NL, et al. Virology. 1995 Sep 10;212(1):102-10. doi: 10.1006/viro.1995.1458. Virology. 1995. PMID: 7676619 - Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
Kinney RM, Chang GJ, Tsuchiya KR, Sneider JM, Roehrig JT, Woodward TM, Trent DW. Kinney RM, et al. J Virol. 1993 Mar;67(3):1269-77. doi: 10.1128/JVI.67.3.1269-1277.1993. J Virol. 1993. PMID: 7679745 Free PMC article. - Towards synthetic viruses.
Zuber G, Dauty E, Nothisen M, Belguise P, Behr JP. Zuber G, et al. Adv Drug Deliv Rev. 2001 Nov 19;52(3):245-53. doi: 10.1016/s0169-409x(01)00213-7. Adv Drug Deliv Rev. 2001. PMID: 11718949 Review.
Cited by
- Replication of the Venezuelan Equine Encephalitis Vaccine from a Synthetic PCR Fragment.
Mathew C, Tucker C, Tretyakova I, Pushko P. Mathew C, et al. Pharmaceutics. 2024 Sep 17;16(9):1217. doi: 10.3390/pharmaceutics16091217. Pharmaceutics. 2024. PMID: 39339253 Free PMC article. - In Vitro and In Vivo Phenotypes of Venezuelan, Eastern and Western Equine Encephalitis Viruses Derived from cDNA Clones of Human Isolates.
Gardner CL, Sun C, Dunn MD, Gilliland TC Jr, Trobaugh DW, Terada Y, Reed DS, Hartman AL, Klimstra WB. Gardner CL, et al. Viruses. 2022 Dec 20;15(1):5. doi: 10.3390/v15010005. Viruses. 2022. PMID: 36680046 Free PMC article. - Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the Coronaviridae and Togaviridae families (Review).
Babaeimarzangou SS, Zaker H, Soleimannezhadbari E, Gamchi NS, Kazeminia M, Tarighi S, Seyedian H, Tsatsakis A, Spandidos DA, Margina D. Babaeimarzangou SS, et al. Exp Ther Med. 2022 Nov 30;25(1):42. doi: 10.3892/etm.2022.11741. eCollection 2023 Jan. Exp Ther Med. 2022. PMID: 36569444 Free PMC article. Review. - CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251.
Hucke FIL, Bestehorn-Willmann M, Bassetto M, Brancale A, Zanetta P, Bugert JJ. Hucke FIL, et al. Virus Genes. 2022 Jun;58(3):188-202. doi: 10.1007/s11262-022-01892-x. Epub 2022 Mar 26. Virus Genes. 2022. PMID: 35347588 Free PMC article. - Construction and characterization of a full-length infectious clone of Getah virus in vivo.
Ren T, Min X, Mo Q, Wang Y, Wang H, Chen Y, Ouyang K, Huang W, Wei Z. Ren T, et al. Virol Sin. 2022 Jun;37(3):348-357. doi: 10.1016/j.virs.2022.03.007. Epub 2022 Mar 11. Virol Sin. 2022. PMID: 35288349 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources